Tuberculosis : Integrated Studies for a Complex Disease / edited by Nima Rezaei
1. Introduction on Tuberculosis: Integrated Studies for a Complex Disease -- 2. Global Tuberculosis Epidemiology -- 3. Heterogeneity in Tuberculosis -- 4. The Unequivocal Relationship between Tuberculosis and Tobacco: Integration of Two Maladies -- 5. Relationship between Pre-existing Cancer and Tuberculosis -- 6. Laboratory Diagnosis of Tuberculosis -- 7. The Role of Diagnostic Microdevices in the Fight Against Tuberculosis -- 8. Immunodiagnostics of Tuberculosis: Recent Discoveries -- 9. Role of Bronchoscopy in Diagnostics and Treatment of Tuberculosis -- 10. Diagnosis of Childhood Tuberculosis in Low- and Middle-income Countries -- 11. Pediatric Tuberculosis: Current Evidence for Laboratory Diagnosis -- 12. A Multidisciplinary Approach Towards Finding and Treating All Tuberculosis Patients -- 13. Chemotherapy for Drug-Susceptible Tuberculosis -- 14. The Pharmacokinetic and Pharmacodynamic Properties of Antitubercular Medications -- 15. Immune Approaches In Tuberculosis Treatment -- 16. Inhalation Therapy in Pulmonary Tuberculosis -- 17. Role of Micronutrients in Tuberculosis Management -- 18. Drug Resistance in Tuberculosis: Mechanisms, Diagnosis, New Responses, and the Need for An Integrated Approach -- 19. Resistance in Tuberculosis: Molecular Mechanisms and Modulation -- 20. Personalized Tuberculosis Care for Drug-Resistant Tuberculosis -- 21. Important Targets and Inhibitors of Mycobacterium Tuberculosis -- 22. P-type ATPases: A Relevant Component in Mycobacterium tuberculosis Viability -- 23. The Challenges of Antitubercular Drug Discovery -- 24. Exploring Decaprenylphosphoryl-β-D-ribose 2’-Epimerase 1 (DprE1): A Target for Anti-Tubercular Drugs -- 25. Energy Pathways in Mycobacterium Tuberculosis -- 26. Drug Discovery for Non-Tuberculous Mycobacteria: Recent Updates -- 27. Challenges for Contact Tracing and Tuberculosis Preventive Therapy Scale-up -- 28. Exploring Problematizations Underlying Tuberculosis Control Strategies: A Cross-Country Analysis of India and Kenya -- 29. Challenges in Prevention and Management of Tuberculosis -- 30. Tuberculosis in Contacts and Healthcare Workers -- 31. Tuberculosis Among People Who Use Drugs: Multilevel Considerations for Prevention, Diagnosis, and Treatment -- 32. Anti-Tumor Necrosis Factor-α Antagonists and Tuberculosis -- 33. Breast Tuberculosis -- 34. Central Nervous System Tuberculosis: Pathogenesis, Diagnosis, and Management -- 35. Pleural Tuberculosis -- 36. Ocular Tuberculosis -- 37. Ocular Tuberculosis: Biomarkers for Risk Stratification -- 38. Bone and Joint Tuberculosis -- 39. Abdominal Tuberculosis: Pathogenesis, Clinical Features, and Diagnosis -- 40. Bovine Tuberculosis at The Interface of Cattle, Wildlife, and Humans -- 41. Evolution and Molecular Characteristics of Mycobacterium Tuberculosis and Mycobacterium Bovis -- 42. Animal Tuberculosis: Gross Lesions and Anatomopathological Diagnosis -- 43. Estimation of Microbial Mutation Rates in Tuberculosis Research -- 44. The Role of Epigenetics in the Development of Anti-Tuberculosis Drug Resistance -- 45. Multiomics Integration of Tuberculosis Pathogenesis -- 46. Lung Microbiome in Tuberculosis -- 47. The Correlation of Microbiota and Host Epigenome in Tuberculosis -- 48. The Pathogenesis and Progression of Sarcoidosis from The Standpoint of Tuberculosis -- 49. Tuberculosis: A Historical and Global Bioethical Perspective -- 50. The Problem of Tuberculosis: Myths, Stigma, and Mimics -- 51. Tuberculosis: Integrated Studies for a Complex Disease 2050..
Tuberculosis have been documented since antiquity and the search of the microbes that cause this disease started more than three hundred years ago. Nevertheless, tuberculosis remains an important global health issue, with millions of people affected per year in addition to millions that remain undiagnosed and untreated. Patients with tuberculosis face the full range of recurrence, reinfection, and resistance due to diagnostic, prophylactic, and therapeutic procedures that are not as effective as they should be. In addition, variability in susceptibility to tuberculosis pose a complex problem with numerous interrelated variables. This volume is devoted to the understanding of Tuberculosis focusing on its heterogeneity, its transmission, manifestations, related conditions, diagnosis, treatments, drug resistance and prevention..
Medienart: |
E-Book |
---|
Erscheinungsjahr: |
2023. |
---|---|
Erschienen: |
Cham: Springer International Publishing ; 2023. Cham: Imprint: Springer ; 2023. |
Ausgabe: |
1st ed. 2023. |
Reihe: |
Integrated Science - 11 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rezaei, Nima [HerausgeberIn] |
---|
Links: |
doi.org [lizenzpflichtig] |
---|
ISBN: |
---|
Themen: |
Biology |
---|
Umfang: |
1 Online-Ressource(XXIV, 1116 p. 363 illus., 239 illus. in color.) |
---|
doi: |
10.1007/978-3-031-15955-8 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1841951536 |
---|
LEADER | 01000cam a22002652 4500 | ||
---|---|---|---|
001 | 1841951536 | ||
003 | DE-627 | ||
005 | 20240106235409.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230411s2023 sz |||||o 00| ||eng c | ||
020 | |a 9783031159558 |9 978-3-031-15955-8 | ||
024 | 7 | |a 10.1007/978-3-031-15955-8 |2 doi | |
035 | |a (DE-627)1841951536 | ||
035 | |a (DE-599)KEP091150094 | ||
035 | |a (DE-He213)978-3-031-15955-8 | ||
035 | |a (EBP)091150094 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
044 | |c XA-CH | ||
072 | 7 | |a MBGR |2 bicssc | |
072 | 7 | |a MED000000 |2 bisacsh | |
245 | 1 | 0 | |a Tuberculosis |b Integrated Studies for a Complex Disease |c edited by Nima Rezaei |
250 | |a 1st ed. 2023. | ||
264 | 1 | |a Cham |b Springer International Publishing |c 2023. | |
264 | 1 | |a Cham |b Imprint: Springer |c 2023. | |
300 | |a 1 Online-Ressource(XXIV, 1116 p. 363 illus., 239 illus. in color.) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
490 | 0 | |a Integrated Science |v 11 | |
520 | |a 1. Introduction on Tuberculosis: Integrated Studies for a Complex Disease -- 2. Global Tuberculosis Epidemiology -- 3. Heterogeneity in Tuberculosis -- 4. The Unequivocal Relationship between Tuberculosis and Tobacco: Integration of Two Maladies -- 5. Relationship between Pre-existing Cancer and Tuberculosis -- 6. Laboratory Diagnosis of Tuberculosis -- 7. The Role of Diagnostic Microdevices in the Fight Against Tuberculosis -- 8. Immunodiagnostics of Tuberculosis: Recent Discoveries -- 9. Role of Bronchoscopy in Diagnostics and Treatment of Tuberculosis -- 10. Diagnosis of Childhood Tuberculosis in Low- and Middle-income Countries -- 11. Pediatric Tuberculosis: Current Evidence for Laboratory Diagnosis -- 12. A Multidisciplinary Approach Towards Finding and Treating All Tuberculosis Patients -- 13. Chemotherapy for Drug-Susceptible Tuberculosis -- 14. The Pharmacokinetic and Pharmacodynamic Properties of Antitubercular Medications -- 15. Immune Approaches In Tuberculosis Treatment -- 16. Inhalation Therapy in Pulmonary Tuberculosis -- 17. Role of Micronutrients in Tuberculosis Management -- 18. Drug Resistance in Tuberculosis: Mechanisms, Diagnosis, New Responses, and the Need for An Integrated Approach -- 19. Resistance in Tuberculosis: Molecular Mechanisms and Modulation -- 20. Personalized Tuberculosis Care for Drug-Resistant Tuberculosis -- 21. Important Targets and Inhibitors of Mycobacterium Tuberculosis -- 22. P-type ATPases: A Relevant Component in Mycobacterium tuberculosis Viability -- 23. The Challenges of Antitubercular Drug Discovery -- 24. Exploring Decaprenylphosphoryl-β-D-ribose 2’-Epimerase 1 (DprE1): A Target for Anti-Tubercular Drugs -- 25. Energy Pathways in Mycobacterium Tuberculosis -- 26. Drug Discovery for Non-Tuberculous Mycobacteria: Recent Updates -- 27. Challenges for Contact Tracing and Tuberculosis Preventive Therapy Scale-up -- 28. Exploring Problematizations Underlying Tuberculosis Control Strategies: A Cross-Country Analysis of India and Kenya -- 29. Challenges in Prevention and Management of Tuberculosis -- 30. Tuberculosis in Contacts and Healthcare Workers -- 31. Tuberculosis Among People Who Use Drugs: Multilevel Considerations for Prevention, Diagnosis, and Treatment -- 32. Anti-Tumor Necrosis Factor-α Antagonists and Tuberculosis -- 33. Breast Tuberculosis -- 34. Central Nervous System Tuberculosis: Pathogenesis, Diagnosis, and Management -- 35. Pleural Tuberculosis -- 36. Ocular Tuberculosis -- 37. Ocular Tuberculosis: Biomarkers for Risk Stratification -- 38. Bone and Joint Tuberculosis -- 39. Abdominal Tuberculosis: Pathogenesis, Clinical Features, and Diagnosis -- 40. Bovine Tuberculosis at The Interface of Cattle, Wildlife, and Humans -- 41. Evolution and Molecular Characteristics of Mycobacterium Tuberculosis and Mycobacterium Bovis -- 42. Animal Tuberculosis: Gross Lesions and Anatomopathological Diagnosis -- 43. Estimation of Microbial Mutation Rates in Tuberculosis Research -- 44. The Role of Epigenetics in the Development of Anti-Tuberculosis Drug Resistance -- 45. Multiomics Integration of Tuberculosis Pathogenesis -- 46. Lung Microbiome in Tuberculosis -- 47. The Correlation of Microbiota and Host Epigenome in Tuberculosis -- 48. The Pathogenesis and Progression of Sarcoidosis from The Standpoint of Tuberculosis -- 49. Tuberculosis: A Historical and Global Bioethical Perspective -- 50. The Problem of Tuberculosis: Myths, Stigma, and Mimics -- 51. Tuberculosis: Integrated Studies for a Complex Disease 2050. | ||
520 | |a Tuberculosis have been documented since antiquity and the search of the microbes that cause this disease started more than three hundred years ago. Nevertheless, tuberculosis remains an important global health issue, with millions of people affected per year in addition to millions that remain undiagnosed and untreated. Patients with tuberculosis face the full range of recurrence, reinfection, and resistance due to diagnostic, prophylactic, and therapeutic procedures that are not as effective as they should be. In addition, variability in susceptibility to tuberculosis pose a complex problem with numerous interrelated variables. This volume is devoted to the understanding of Tuberculosis focusing on its heterogeneity, its transmission, manifestations, related conditions, diagnosis, treatments, drug resistance and prevention. | ||
650 | 0 | |a Medicine—Research. | |
650 | 0 | |a Biology—Research. | |
650 | 0 | |a Clinical medicine—Research. | |
650 | 0 | |a Diseases—Causes and theories of causation. | |
650 | 0 | |a Epidemiology. | |
650 | 0 | |a Biology | |
650 | 0 | |a Clinical medicine | |
650 | 0 | |a Medicine | |
650 | 0 | |a Diseases | |
700 | 1 | |a Rezaei, Nima |e herausgeberin |4 edt | |
776 | 1 | |z 9783031159541 | |
776 | 1 | |z 9783031159565 | |
776 | 1 | |z 9783031159572 | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783031159541 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783031159565 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783031159572 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-15955-8 |m X:SPRINGER |x Resolving-System |z lizenzpflichtig |
912 | |a ZDB-2-SEB |b 2023 | ||
912 | |a ZDB-2-SBL |b 2023 | ||
912 | |a ZDB-2-SXB |b 2023 | ||
912 | |a GBV_ILN_22 | ||
912 | |a ISIL_DE-18 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a GBV_ILN_22_i06404 | ||
912 | |a GBV_ILN_23 | ||
912 | |a ISIL_DE-830 | ||
912 | |a GBV_ILN_34 | ||
912 | |a ISIL_DE-18-302 | ||
912 | |a GBV_ILN_62 | ||
912 | |a ISIL_DE-28 | ||
912 | |a GBV_ILN_65 | ||
912 | |a ISIL_DE-3 | ||
912 | |a GBV_ILN_100 | ||
912 | |a ISIL_DE-Ma9 | ||
912 | |a GBV_ILN_101 | ||
912 | |a ISIL_DE-Ma14 | ||
912 | |a GBV_ILN_120 | ||
912 | |a ISIL_DE-715 | ||
912 | |a GBV_ILN_130 | ||
912 | |a ISIL_DE-700 | ||
912 | |a GBV_ILN_132 | ||
912 | |a ISIL_DE-959 | ||
912 | |a GBV_ILN_186 | ||
912 | |a ISIL_DE-519 | ||
912 | |a GBV_ILN_285 | ||
912 | |a ISIL_DE-517 | ||
912 | |a GBV_ILN_381 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a ISIL_DE-25 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a ISIL_DE-14 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a ISIL_DE-15 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a ISIL_DE-90 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a ISIL_DE-93 | ||
912 | |a GBV_ILN_2017 | ||
912 | |a ISIL_DE-576 | ||
912 | |a GBV_ILN_2068 | ||
912 | |a ISIL_DE-Fn1 | ||
912 | |a GBV_ILN_2108 | ||
912 | |a ISIL_DE-991 | ||
912 | |a GBV_ILN_2119 | ||
912 | |a ISIL_DE-943 | ||
912 | |a GBV_ILN_2129 | ||
912 | |a ISIL_DE-Ofb1 | ||
951 | |a BO | ||
953 | |2 045F |a 610.72 | ||
980 | |2 22 |1 01 |x 0018 |b 4307966708 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h h64 Springer Biomedical |k Campuslizenz Universität Hamburg. - Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y zi06404 |z 13-04-23 | ||
980 | |2 23 |1 01 |x 0830 |b 4307972376 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h olr-springer |u i |y z |z 13-04-23 | ||
980 | |2 34 |1 01 |x 3551 |b 4307905350 |h OLR-SEB-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y zi002 |z 12-04-23 | ||
980 | |2 62 |1 01 |x 0028 |b 4307999568 |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 13-04-23 | ||
980 | |2 65 |1 01 |x 0003 |b 4308004950 |c 03 |f --%%-- |d ebook |e --%%-- |j --%%-- |h OLR-SEB-ZDB-2-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y k3o |z 13-04-23 | ||
980 | |2 100 |1 01 |x 3100 |b 4307985826 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |c 09 |f --%%-- |d eBook Springer |e --%%-- |j --%%-- |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 13-04-23 | ||
980 | |2 101 |1 01 |x 3101 |b 4307989643 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |c 09 |f --%%-- |d eBook Springer |e --%%-- |j --%%-- |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 13-04-23 | ||
980 | |2 120 |1 01 |x 0715 |b 4324867313 |c 00 |f --%%-- |d --%%-- |e g |j --%%-- |h alma |y z |z 24-05-23 | ||
980 | |2 130 |1 01 |x 0700 |b 4307993748 |h OLR-SEB |k Vervielfältigungen (z. B. Kopien, Downloads) nur für den eigenen wissenschaftlichen Gebrauch. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots |y z |z 13-04-23 | ||
980 | |2 132 |1 01 |x 0959 |b 4307891694 |h OLR-ESP-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y k |z 12-04-23 | ||
980 | |2 186 |1 01 |x 0519 |b 4307949919 |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 12-04-23 | ||
980 | |2 285 |1 01 |x 0517 |b 4307994914 |c 00 |f --%%-- |d --%%-- |e s |j --%%-- |h OLR-ESP-SBL |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y z |z 13-04-23 | ||
980 | |2 381 |1 01 |x 4381 |b 430790222X |h OLR-SEB |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots |y z |z 12-04-23 | ||
980 | |2 2003 |1 01 |x DE-25 |b 4307292057 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Universitätslizenz |y l01 |z 11-04-23 | ||
980 | |2 2006 |1 01 |x DE-14 |b 4307351029 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 11-04-23 | ||
980 | |2 2010 |1 01 |x DE-15 |b 4307351045 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Campuslizenz |y l01 |z 11-04-23 | ||
980 | |2 2014 |1 01 |x DE-90 |b 4307351053 |c 00 |f --%%-- |d --%%-- |e --%%-- |j kp |y l01 |z 11-04-23 | ||
980 | |2 2015 |1 01 |x DE-93 |b 4307351061 |c 00 |f --%%-- |d --%%-- |e p |j --%%-- |k Campuslizenz |y l01 |z 11-04-23 | ||
980 | |2 2017 |1 01 |x DE-576 |b 430735107X |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Besitznachweis BSZ nur für Dateneinspielung, keine echte Lizenz vorhanden |y l01 |z 11-04-23 | ||
980 | |2 2068 |1 01 |x DE-Fn1 |b 4307292065 |c 00 |f --%%-- |d eBook Springer |e --%%-- |j en |y l01 |z 11-04-23 | ||
980 | |2 2108 |1 01 |x DE-991 |b 4307292073 |c 00 |f --%%-- |d eBook Springer |e --%%-- |j kp |k Elektronischer Volltext - Campuslizenz |y l01 |z 11-04-23 | ||
980 | |2 2119 |1 01 |x DE-943 |b 4307292081 |c 00 |f --%%-- |d eBook Springer |e --%%-- |j n |k Elektronischer Volltext - Campuslizenz |y l01 |z 11-04-23 | ||
980 | |2 2129 |1 01 |x DE-Ofb1 |b 4511791414 |c 00 |f --%%-- |d E-Book Springer |e --%%-- |j n |y l01 |z 15-04-24 | ||
981 | |2 22 |1 01 |x 0018 |y Volltextzugang |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 22 |1 01 |x 0018 |y Nur für Angehörige der Universität Hamburg: Volltextzugang von außerhalb des Campus |r http://emedien.sub.uni-hamburg.de/han/SpringerEbooksUKE/doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 23 |1 01 |x 0830 |y Springer EBook |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 34 |1 01 |x 3551 |y Zugriff nur im dem Netz der HAW-Hamburg |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 62 |1 01 |x 0028 |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 65 |1 01 |x 0003 |y Volltextzugang Campus |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 100 |1 01 |x 3100 |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 100 |1 01 |x 3100 |y für Uniangehörige: Zugang weltweit |r https://han.med.uni-magdeburg.de/han/SPR-eBook-BiomedicalandLifeScience-einzeln/doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 101 |1 01 |x 3101 |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 101 |1 01 |x 3101 |y für Uniangehörige: Zugang weltweit |r https://han.med.uni-magdeburg.de/han/SPR-eBook-BiomedicalandLifeScience-einzeln/doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 120 |1 01 |x 0715 |r http://49gbv-uob-primo.hosted.exlibrisgroup.com/openurl/49GBV_UOB/UOB_services_page?u.ignore_date_coverage=true&rft.mms_id=991016174076203501 | ||
981 | |2 130 |1 01 |x 0700 |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 132 |1 01 |x 0959 |y Zugriff nur für Angehörige der Hochschule Osnabrück im Hochschulnetz |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 186 |1 01 |x 0519 |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 285 |1 01 |x 0517 |y E-books (Springer) |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 381 |1 01 |x 4381 |y Zugriff nur für GEOMAR-Mitarbeiter / Access for GEOMAR employees only |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 2003 |1 01 |x DE-25 |r https://www.redi-bw.de/start/unifr/EBooks-springer/10.1007/978-3-031-15955-8 | ||
981 | |2 2006 |1 01 |x DE-14 |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 2010 |1 01 |x DE-15 |y Online-Zugriff |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 2014 |1 01 |x DE-90 |y Zugang im Netz des KIT |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 2015 |1 01 |x DE-93 |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 2068 |1 01 |x DE-Fn1 |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 2108 |1 01 |x DE-991 |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 2119 |1 01 |x DE-943 |r https://doi.org/10.1007/978-3-031-15955-8 | ||
981 | |2 2129 |1 01 |x DE-Ofb1 |r https://doi.org/10.1007/978-3-031-15955-8 | ||
982 | |2 132 |1 01 |x 0959 |8 00 |a EBooks Springer Biomedical and Life Sciences | ||
985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
995 | |2 22 |1 01 |x 0018 |a h64 Springer Biomedical | ||
995 | |2 23 |1 01 |x 0830 |a olr-springer | ||
995 | |2 34 |1 01 |x 3551 |a OLR-SEB-SBL | ||
995 | |2 65 |1 01 |x 0003 |a OLR-SEB-ZDB-2-SBL | ||
995 | |2 100 |1 01 |x 3100 |a OLR-SEB | ||
995 | |2 101 |1 01 |x 3101 |a OLR-SEB | ||
995 | |2 120 |1 01 |x 0715 |a alma | ||
995 | |2 130 |1 01 |x 0700 |a OLR-SEB | ||
995 | |2 132 |1 01 |x 0959 |a OLR-ESP-SBL | ||
995 | |2 132 |1 01 |x 0959 |a OLR-ESP | ||
995 | |2 186 |1 01 |x 0519 |a OLR-SEB | ||
995 | |2 285 |1 01 |x 0517 |a OLR-ESP-SBL | ||
995 | |2 381 |1 01 |x 4381 |a OLR-SEB | ||
998 | |2 23 |1 01 |x 0830 |0 2023.04.13 | ||
998 | |2 2003 |1 01 |x DE-25 |0 11-04-23 |f 17 |